Correa BNR, López FJ, Sánchez DKP, Luis RMÁ

Language: Spanish
References: 10
Page: 575-580
PDF size: 271.41 Kb.

ABSTRACT

Acute kidney injury is a frequent condition in critically ill patients, who may require renal replacement therapy. The prescription modality continues to be a fundamental pillar due to the cost-benefit involved. The prescription of a replacement therapy modality is still unclear in the indications and criteria established in the literature (ELAIN, AKIKI, IDEAL ICU, STARRT AKI and AKIKI-2) for subjecting patients with controversial critical pathologies to continuous and commonly manipulated slow renal therapies at convenience in intensive care units, even in an empirical or industry-influenced manner. In analyzing this problem in the lack of congruence in decision making in our hospital center, a local study was carried out in order to obtain the outcome of patients who initiate continuous slow renal replacement therapy in their first hours of stay in the unit, observing a survival rate without a relevant clinical effect. Considering the limitations such as the heterogeneity of the variables involved (severity of the conditioning disease, prescription, modalities, demographic data of the population studied), our working group conducted the following study in order to obtain lines of research with data from the population of southeastern Mexico.

REFERENCES

1. Bagshaw SM, Darmon M, Ostermann M, et al. Current state of the art for renal replacement therapy in critically ill patients with acute kidney injury. Intensive Care Med. 2017;43:841-854. Available in: https://doi.org/10.1007/s00134-017-4762-8

2. Correa S, Montero O. Lesión renal aguda ¿Qué hay de nuevo en la evidencia? RFS Revista Facultad de Salud. 2023; 99-113. Disponible en: http://journalusco.edu.co/index.php/RFS

3. Roesler E. Insuficiencia renal aguda en pacientes críticos. Revista Chilena de Urología. 2016;81:20-29.

4. Fuentes AV. Terapias de reemplazo renal agudo en pacientes críticos. Rev Med Clin Condes. 2024;35(1):14-21. doi: 10.1016/j.rmclc.2023.12.001.

5. Zarbock A, Kellum JA, Schmidt C, et al. Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury. JAMA. 2016;315(20):2190.

6. Gaudry S, Hajage D, Schortgen F, et al. Initiation strategies for renal-replacement therapy in the intensive care unit. N Engl J Med. 2016;375(2):122-133.

7. Barbar SD, Clere-Jehl R, Bourredjem A, et al. Timing of renal-replacement therapy in patients with acute kidney injury and sepsis. N Engl J Med. 2018;379(15):1431-1442.

8. STARRT-AKI Investigators; Canadian Critical Care Trials Group; Australian and New Zealand Intensive Care Society Clinical Trials Group, et al. Timing of initiation of renal-replacement therapy in acute kidney injury. N Engl J Med. 2020;383(3):240-251.

9. Gaudry S, Hajage D, Martin-Lefevre L, et al. Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2): a multicentre, open-label, randomised, controlled trial. Lancet. 2021;397(10281):1293-1300.

10. Gaudry S, Grolleau F, Barbar S, et al. Continuous renal replacement therapy versus intermittent hemodialysis as first modality for renal replacement therapy in severe acute kidney injury: a secondary analysis of AKIKI and IDEAL-ICU studies. Crit Care. 2022;26(1):93.